CRISPRX

CRISPR Therapeutics AG

Application Filed: 2023-03-08
Trademark Application Details
Trademark Logo CRISPRX

The mark consists of of the term CRISPRX.

Mark For: CRISPRX™ trademark registration is intended to cover the categories of scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals.

Status

2023-03-11 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number97828604
Mark Literal ElementsCRISPRX
Mark Drawing Type-
Mark TypeService Mark
Standard Character ClaimNo
Current LocationNEW APPLICATION PROCESSING 2023-03-11
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 100: Miscellaneous
  • 101: Advertising and Business
Primary International Class
  • 042 - Primary Class
  • (Computer, scientific & legal) Scientific and technological services and research and design relating thereto: industrial analysis and research services; design and development of computer hardware and software; legal services.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameTiffany D. Gehrke
Attorney Docket Number33324/60075

Timeline

2023-03-08Application Filed
2023-03-11Location: NEW APPLICATION PROCESSING
2023-03-11Status: Live/Pending
2023-03-11Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-03-11Transaction Date

Trademark Parties (Applicants & Owners)

Party: CRISPR Therapeutics AG
AddressBaarerstrasse 14 ZUG V8 SWITZERLAND 6300
Legal Entity TypeAktiengesellschaft
Legal Entity StateSWITZERLAND

Documents

Application2023-03-08
Drawing2023-03-08

Attorney of Record

TIFFANY D. GEHRKE
MARSHALL, GERSTEIN & BORUN LLP
233 SOUTH WACKER DRIVE
SUITE 6300
CHICAGO, IL 60606

Good, Services, and Codes

International Codes:42
U.S. Codes:100,101
Type CodeType
DM0000The mark consists of of the term CRISPRX.

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED2023-03-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed